SuperworthBridgeBio Pharma shares outstanding BBIO
Diluted shares outstanding, averaged over each quarter, from 2018.
- Latest quarter, to Jun 30, 2026
- 195.8M
- On a year earlier
- +2.8%
- more shares
BridgeBio Pharma had 195.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 2.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 193.6M | +2% |
| FY2024 | 189.4M | +9% |
| FY2023 | 174.4M | +17% |
| FY2022 | 149.3M | +3% |
| FY2021 | 145.3M | +22% |
| FY2020 | 119M | +1% |
| FY2019 | 117.7M | +58% |
| FY2018 | 74.6M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 195.8M | +3% | |
| Q1 FY26 | 194.8M | +2% | |
| Q4 FY25 | 193.6M | +2% | |
| Q3 FY25 | 191.9M | +2% | |
| Q2 FY25 | 190.5M | +2% | |
| Q1 FY25 | 190.1M | +6% | |
| Q4 FY24 | 189.4M | +9% | |
| Q3 FY24 | 188.5M | +15% | |
| Q2 FY24 | 187.6M | +17% | |
| Q1 FY24 | 178.7M | +17% | |
| Q4 FY23 | 174.4M | +17% | |
| Q3 FY23 | 163.3M | +10% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on BridgeBio Pharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.